Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avitar Inc. stock logo
AVTI
Avitar
$0.00
$0.00
$0.00
N/AN/A20 shs20 shs
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$9.38
+1.8%
$9.97
$9.17
$14.14
N/A0.34188,180 shs172,822 shs
PCGR
PC Group
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
$0.00
$0.00
$0.00
N/AN/AN/AN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avitar Inc. stock logo
AVTI
Avitar
0.00%0.00%0.00%0.00%0.00%
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
+1.85%-3.89%-2.70%-12.17%-21.64%
PCGR
PC Group
0.00%0.00%0.00%0.00%0.00%
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
PCGR
PC Group
N/AN/AN/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avitar Inc. stock logo
AVTI
Avitar
0.00
N/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
2.40
HoldN/AN/A
PCGR
PC Group
0.00
N/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CLPBY, AVTI, PFND, and PCGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
5/7/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$3.93BN/AN/AN/AN/AN/A
PCGR
PC Group
N/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avitar Inc. stock logo
AVTI
Avitar
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$734.56M$0.3031.2723.453.5016.38%27.29%9.40%8/19/2025 (Estimated)
PCGR
PC Group
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest CLPBY, AVTI, PFND, and PCGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q2 2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.0874$0.06-$0.0274$0.06$7.02 billion$1.05 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.080.85%N/A26.67%N/A
PCGR
PC Group
N/AN/AN/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/AN/AN/A

Latest CLPBY, AVTI, PFND, and PCGR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/16/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.03892.02%5/16/20255/19/20255/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.98
0.95
0.61
PCGR
PC Group
N/AN/AN/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Avitar Inc. stock logo
AVTI
Avitar
N/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
PCGR
PC Group
N/A
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
N/A

Insider Ownership

CompanyInsider Ownership
Avitar Inc. stock logo
AVTI
Avitar
7.40%
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
PCGR
PC Group
53.78%
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
15.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avitar Inc. stock logo
AVTI
Avitar
36N/AN/ANot Optionable
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
16,875N/AN/ANot Optionable
PCGR
PC Group
289N/AN/ANot Optionable
Pathfinder Cell Therapy Inc. stock logo
PFND
Pathfinder Cell Therapy
1N/AN/ANot Optionable

Recent News About These Companies

t-cell therapy
Pathfinder Cell Therapy, Inc. (PFND)
Cell Therapy Repairs Cornea Damage With Patient’s Own Stem Cells
Cell Replacement Therapy for Parkinson's Disease
Gene and Cell Therapy
Your First Therapy Session
Therapy for Teens: What to Expect
Therapy: Does It Ever End?
Avitar stock logo

Avitar OTCMKTS:AVTI

Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.

Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBY

$9.38 +0.17 (+1.85%)
As of 06/20/2025 03:58 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

PC Group OTCMKTS:PCGR

PC Group, Inc., through its subsidiaries, offers personal care products for the private label retail, medical, and therapeutic markets primarily in the United States, Canada, and Europe. Its personal care products include soaps, cleansers, toners, moisturizers, exfoliants, and facial masks, as well as over-the-counter drug products, such as acne soaps; and gel-based products, including gloves and sock products that are used for cosmetic and scar management purposes. The company's gel-based orthopedic products include digitcare products, diabetes management products, products that protect the hands and wrists, gel sheeting products for various applications, and pressure, friction, and shear force absorption products, as well as products for the treatment of common orthopedic and footcare conditions; and gel-based prosthetic products for the treatment of common orthopedic and footcare conditions. PC Group sells its personal care products through account representatives to health and beauty companies, specialty retailers, cosmetics companies, direct marketing companies, amenities companies, health clubs and spas, and catalog companies; and medical products through national and regional account managers, field sales representatives, and inside sales representatives, as well as through medical distributors. The company was formerly known as Langer, Inc. and changed its name to PC Group, Inc. in July 2009 as a result of business focus shift to personal care products business. PC Group, Inc. was founded in 1971 and is headquartered in New York, New York.

Pathfinder Cell Therapy stock logo

Pathfinder Cell Therapy OTCMKTS:PFND

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.